{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:15:06Z","timestamp":1791976506897,"version":"4.4.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40266-019-00657-w","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T06:27:30Z","timestamp":1557383250000},"page":"101-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6992-6712","authenticated-orcid":false,"given":"Germain","family":"Honvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-752X","authenticated-orcid":false,"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Rannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Rygaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Geerinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rabenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"McAlindon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Fuggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Arden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-9393","authenticated-orcid":false,"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"issue":"9783","key":"657_CR1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(11)60243-2 .","journal-title":"Lancet"},{"issue":"11","key":"657_CR2","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.joca.2011.08.009","volume":"19","author":"D Pereira","year":"2011","unstructured":"Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartil. 2011;19(11):1270\u201385. https:\/\/doi.org\/10.1016\/j.joca.2011.08.009 .","journal-title":"Osteoarthr Cartil"},{"issue":"9859","key":"657_CR3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/s0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163\u201396. https:\/\/doi.org\/10.1016\/s0140-6736(12)61729-2 .","journal-title":"Lancet"},{"issue":"3","key":"657_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","volume":"44","author":"O Bruyere","year":"2014","unstructured":"Bruyere O, Cooper C, Pelletier JP, Branco J, Brandi ML, Guillemin F, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253\u201363. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.014 .","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"657_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","volume":"75","author":"E Roberts","year":"2016","unstructured":"Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206914 .","journal-title":"Ann Rheum Dis"},{"issue":"9894","key":"657_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769\u201379. https:\/\/doi.org\/10.1016\/s0140-6736(13)60900-9 .","journal-title":"Lancet"},{"issue":"12","key":"657_CR7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2165\/11633470-000000000-00000","volume":"35","author":"J Castellsague","year":"2012","unstructured":"Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127\u201346. https:\/\/doi.org\/10.2165\/11633470-000000000-00000 .","journal-title":"Drug Saf"},{"key":"657_CR8","doi-asserted-by":"publisher","first-page":"CD003115","DOI":"10.1002\/14651858.cd003115.pub4","volume":"9","author":"BR da Costa","year":"2014","unstructured":"da Costa BR, Nuesch E, Kasteler R, Husni E, Welch V, Rutjes AW, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2014;9:CD003115. https:\/\/doi.org\/10.1002\/14651858.cd003115.pub4 .","journal-title":"Cochrane Database Syst Rev"},{"key":"657_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2017.12.001","author":"RZ Megale","year":"2017","unstructured":"Megale RZ, Deveza LA, Blyth FM, Naganathan V, Ferreira PH, McLachlan AJ, et al. Efficacy and safety of oral and transdermal opioid analgesics for musculoskeletal pain in older adults: a systematic review of randomized, placebo-controlled trials. J Pain. 2017. https:\/\/doi.org\/10.1016\/j.jpain.2017.12.001 .","journal-title":"J Pain"},{"issue":"10","key":"657_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-014-1734-6","volume":"70","author":"M Wehling","year":"2014","unstructured":"Wehling M. Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects. Eur J Clin Pharmacol. 2014;70(10):1159\u201372. https:\/\/doi.org\/10.1007\/s00228-014-1734-6 .","journal-title":"Eur J Clin Pharmacol"},{"key":"657_CR11","first-page":"779","volume-title":"Textbook of rheumatology","author":"L Axelrod","year":"1993","unstructured":"Axelrod L. Glucocorticoids. In: Kelley WN, Harris EDJ, Sledge CB, editors. Textbook of rheumatology. 4th ed. Philadelphia: WB Saunders; 1993. p. 779\u201396.","edition":"4"},{"issue":"5","key":"657_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jbspin.2006.10.009","volume":"74","author":"M Younes","year":"2007","unstructured":"Younes M, Neffati F, Touzi M, Hassen-Zrour S, Fendri Y, Bejia I, et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Jt Bone Spine. 2007;74(5):472\u20136. https:\/\/doi.org\/10.1016\/j.jbspin.2006.10.009 .","journal-title":"Jt Bone Spine"},{"key":"657_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2106\/jbjs.rvw.o.00029","volume":"4","author":"MN Choudhry","year":"2016","unstructured":"Choudhry MN, Malik RA, Charalambous CP. Blood glucose levels following intra-articular steroid injections in patients with diabetes: a systematic review. JBJS Rev. 2016;4:3. https:\/\/doi.org\/10.2106\/jbjs.rvw.o.00029 .","journal-title":"JBJS Rev"},{"issue":"4 Suppl","key":"657_CR14","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.semarthrit.2015.11.008","volume":"45","author":"E Maheu","year":"2016","unstructured":"Maheu E, Rannou F, Reginster JY. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S28\u201333. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.11.008 .","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"657_CR15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/acr.23204","volume":"69","author":"C Cooper","year":"2017","unstructured":"Cooper C, Rannou F, Richette P, Bruyere O, Al-Daghri N, Altman RD, et al. Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice. Arthritis Care Res (Hoboken). 2017;69(9):1287\u201396. https:\/\/doi.org\/10.1002\/acr.23204 .","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"657_CR16","doi-asserted-by":"publisher","first-page":"CD005321","DOI":"10.1002\/14651858.cd005321.pub2","volume":"2","author":"N Bellamy","year":"2006","unstructured":"Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2:CD005321. https:\/\/doi.org\/10.1002\/14651858.cd005321.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"657_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7326\/M14-1231","volume":"162","author":"RR Bannuru","year":"2015","unstructured":"Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162(1):46\u201354. https:\/\/doi.org\/10.7326\/M14-1231 .","journal-title":"Ann Intern Med"},{"issue":"12","key":"657_CR18","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/art.24925","volume":"61","author":"RR Bannuru","year":"2009","unstructured":"Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(12):1704\u201311. https:\/\/doi.org\/10.1002\/art.24925 .","journal-title":"Arthritis Rheum"},{"issue":"6","key":"657_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.joca.2010.09.014","volume":"19","author":"RR Bannuru","year":"2011","unstructured":"Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis\u2013meta-analysis. Osteoarthr Cartil. 2011;19(6):611\u20139. https:\/\/doi.org\/10.1016\/j.joca.2010.09.014 .","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"657_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.PHM.0000156899.18885.06","volume":"84","author":"RJ Petrella","year":"2005","unstructured":"Petrella RJ. Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil. 2005;84(4):278\u201383.","journal-title":"Am J Phys Med Rehabil"},{"issue":"7","key":"657_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-0035-1568992","volume":"29","author":"R Altman","year":"2016","unstructured":"Altman R, Fredericson M, Bhattacharyya SK, Bisson B, Abbott T, Yadalam S, et al. Association between hyaluronic acid injections and time-to-total knee replacement surgery. J Knee Surg. 2016;29(7):564\u201370. https:\/\/doi.org\/10.1055\/s-0035-1568992 .","journal-title":"J Knee Surg"},{"issue":"11","key":"657_CR22","doi-asserted-by":"publisher","first-page":"e0187227","DOI":"10.1371\/journal.pone.0187227","volume":"12","author":"A Delbarre","year":"2017","unstructured":"Delbarre A, Amor B, Bardoulat I, Tetafort A, Pelletier-Fleury N. Do intra-articular hyaluronic acid injections delay total knee replacement in patients with osteoarthritis\u2014a Cox model analysis. PLoS One. 2017;12(11):e0187227. https:\/\/doi.org\/10.1371\/journal.pone.0187227 .","journal-title":"PLoS One"},{"issue":"3","key":"657_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363\u201388. https:\/\/doi.org\/10.1016\/j.joca.2014.01.003 .","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"657_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465\u201374. https:\/\/doi.org\/10.1002\/acr.21596 .","journal-title":"Arthritis Care Res"},{"key":"657_CR25","unstructured":"NICE. Osteoarthritis care and management in adults: methods, evidence and recommendations. National Clinical Guideline Centre. London, UK: National Institute for Health and Care Excellence2014 February 2014. Report No.: CG177."},{"issue":"12","key":"657_CR26","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JWJ, Dieppe P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145\u201355. https:\/\/doi.org\/10.1136\/ard.2003.011742 .","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"657_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.5435\/jaaos-21-09-571","volume":"21","author":"DS Jevsevar","year":"2013","unstructured":"Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21(9):571\u20136. https:\/\/doi.org\/10.5435\/jaaos-21-09-571 .","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"657_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JSM.0000000000000274","volume":"26","author":"TH Trojian","year":"2016","unstructured":"Trojian TH, Concoff AL, Joy SM, Hatzenbuehler JR, Saulsberry WJ, Coleman CI. AMSSM Scientific statement concerning viscosupplementation injections for knee osteoarthritis: importance for individual patient outcomes. Clin J Sport Med. 2016;26(1):1\u201311. https:\/\/doi.org\/10.1097\/JSM.0000000000000274 .","journal-title":"Clin J Sport Med"},{"issue":"2","key":"657_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semarthrit.2015.04.013","volume":"45","author":"RD Altman","year":"2015","unstructured":"Altman RD, Schemitsch E, Bedi A. Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid. Semin Arthritis Rheum. 2015;45(2):132\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.04.013 .","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"657_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2106\/00004623-200403000-00012","volume":"86-A","author":"CT Wang","year":"2004","unstructured":"Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Jt Surg Am. 2004;86-A(3):538\u201345.","journal-title":"J Bone Jt Surg Am"},{"issue":"8","key":"657_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1503\/cmaj.1041203","volume":"172","author":"J Arrich","year":"2005","unstructured":"Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ. 2005;172(8):1039\u201343. https:\/\/doi.org\/10.1503\/cmaj.1041203 .","journal-title":"CMAJ"},{"issue":"8","key":"657_CR32","first-page":"669","volume":"55","author":"JM Medina","year":"2006","unstructured":"Medina JM, Thomas A, Denegar CR. Knee osteoarthritis: should your patient opt for hyaluronic acid injection? J Fam Pract. 2006;55(8):669\u201375.","journal-title":"J Fam Pract"},{"issue":"3","key":"657_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7326\/0003-4819-157-3-201208070-00473","volume":"157","author":"AW Rutjes","year":"2012","unstructured":"Rutjes AW, Juni P, da Costa BR, Trelle S, Nuesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180\u201391. https:\/\/doi.org\/10.7326\/0003-4819-157-3-201208070-00473 .","journal-title":"Ann Intern Med"},{"key":"657_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4137\/cmamd.s12743","volume":"6","author":"LE Miller","year":"2013","unstructured":"Miller LE, Block JE. US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials. Clin Med Insights Arthritis Musculoskelet Disord. 2013;6:57\u201363. https:\/\/doi.org\/10.4137\/cmamd.s12743 .","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"657_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/JPR.S83076","volume":"8","author":"V Strand","year":"2015","unstructured":"Strand V, McIntyre LF, Beach WR, Miller LE, Block JE. Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials. J Pain Res. 2015;8:217\u201328. https:\/\/doi.org\/10.2147\/JPR.S83076 .","journal-title":"J Pain Res."},{"issue":"12","key":"657_CR36","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.joca.2016.07.010","volume":"24","author":"RR Bannuru","year":"2016","unstructured":"Bannuru RR, Osani M, Vaysbrot EE, McAlindon TE. Comparative safety profile of hyaluronic acid products for knee osteoarthritis: a systematic review and network meta-analysis. Osteoarthr Cartil. 2016;24(12):2022\u201341. https:\/\/doi.org\/10.1016\/j.joca.2016.07.010 .","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"657_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/1947603516642271","volume":"7","author":"RR Bannuru","year":"2016","unstructured":"Bannuru RR, Brodie CR, Sullivan MC, McAlindon TE. Safety of repeated injections of sodium hyaluronate (SUPARTZ) for knee osteoarthritis: a systematic review and meta-analysis. Cartilage. 2016;7(4):322\u201332. https:\/\/doi.org\/10.1177\/1947603516642271 .","journal-title":"Cartilage"},{"key":"657_CR38","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). http:\/\/www.handbook.cochrane.org The Cochrane Collaboration; 2011."},{"issue":"10","key":"657_CR39","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005 .","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"657_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"1","key":"657_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53\u201377. https:\/\/doi.org\/10.1002\/sim.2528 .","journal-title":"Stat Med"},{"issue":"29","key":"657_CR42","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/sim.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046\u201367. https:\/\/doi.org\/10.1002\/sim.4040 .","journal-title":"Stat Med"},{"issue":"3","key":"657_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P","volume":"18","author":"SL Normand","year":"1999","unstructured":"Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18(3):321\u201359.","journal-title":"Stat Med"},{"issue":"7414","key":"657_CR44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557 .","journal-title":"BMJ"},{"issue":"11","key":"657_CR45","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186 .","journal-title":"Stat Med"},{"issue":"20","key":"657_CR46","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443\u201357. https:\/\/doi.org\/10.1002\/sim.2380 .","journal-title":"Stat Med"},{"key":"657_CR47","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. https:\/\/doi.org\/10.1136\/bmj.d4002 .","journal-title":"BMJ"},{"issue":"7109","key":"657_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"4","key":"657_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026 .","journal-title":"J Clin Epidemiol."},{"key":"657_CR50","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). http:\/\/gradepro.org .. Evidence Prime, Inc."},{"issue":"11","key":"657_CR51","first-page":"2203","volume":"25","author":"RD Altman","year":"1998","unstructured":"Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25(11):2203\u201312.","journal-title":"J Rheumatol."},{"issue":"8","key":"657_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.joca.2004.04.010","volume":"12","author":"RD Altman","year":"2004","unstructured":"Altman RD, Akermark C, Beaulieu AD, Schnitzer T, Durolane International Study G. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthr Cartil. 2004;12(8):642\u20139.","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"657_CR53","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1185\/03007995.2013.855631","volume":"30","author":"NK Arden","year":"2014","unstructured":"Arden NK, Akermark C, Andersson M, Todman MG, Altman RD. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis. Curr Med Res Opin. 2014;30(2):279\u201386.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"657_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.joca.2008.06.014","volume":"17","author":"AWA Baltzer","year":"2009","unstructured":"Baltzer AWA, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthr Cartil. 2009;17(2):152\u201360.","journal-title":"Osteoarthr Cartil"},{"key":"657_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00003086-200104000-00021","volume":"385","author":"KD Brandt","year":"2001","unstructured":"Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intra-articular sodium hyaluronate in knee osteoarthritis. Clin Orthop Relat Res. 2001;385:130.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"657_CR56","first-page":"25","volume":"15","author":"M Carrabba","year":"1995","unstructured":"Carrabba M, Paresce E, Angelini M, Re KA, Torchiana EEM, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm. 1995;15(1):25.","journal-title":"Eur J Rheumatol Inflamm"},{"issue":"7","key":"657_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3113\/FAI.2008.0657","volume":"29","author":"MM Cohen","year":"2008","unstructured":"Cohen MM, Altman RD, Hollstrom R, Hollstrom C, Sun C, Gipson B. Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int. 2008;29(7):657\u201363.","journal-title":"Foot Ankle Int"},{"issue":"2","key":"657_CR58","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.archger.2011.11.007","volume":"55","author":"JE DeCaria","year":"2012","unstructured":"DeCaria JE, Montero-Odasso M, Wolfe D, Chesworth BM, Petrella RJ. The effect of intra-articular hyaluronic acid treatment on gait velocity in older knee osteoarthritis patients: a randomized, controlled study. Arch Gerontol Geriatr. 2012;55(2):310\u20135.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"657_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2106\/JBJS.J.01763","volume":"94","author":"H DeGroot 3rd","year":"2012","unstructured":"DeGroot H 3rd, Uzunishvili S, Weir R, Al-omari A, Gomes B. Intra-articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double-blind, placebo-controlled study. J Bone Jt Surg Am. 2012;94(1):2\u20138.","journal-title":"J Bone Jt Surg Am"},{"issue":"1","key":"657_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/BMR-2009-0207","volume":"22","author":"D Diracoglu","year":"2009","unstructured":"Diracoglu D, Vural M, Baskent A, Dikici F, Aksoy C. The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis. J Back Musculoskelet Rehabil. 2009;22(1):1\u20139.","journal-title":"J Back Musculoskelet Rehabil"},{"issue":"4","key":"657_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1185\/03007998809114237","volume":"11","author":"AS Dixon","year":"1988","unstructured":"Dixon AS, Jacoby RK, Berry H, Hamilton EB. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin. 1988;11(4):205\u201313.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"657_CR62","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s00167-015-3705-6","volume":"25","author":"G Gormeli","year":"2017","unstructured":"Gormeli G, Gormeli CA, Ataoglu B, Colak C, Aslanturk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2017;25(3):958\u201365.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"657_CR63","first-page":"194760351770373","volume":"101518378","author":"L Hangody","year":"2017","unstructured":"Hangody L, Szody R, Lukasik P, Zgadzaj W, Lenart E, Dokoupilova E, et al. Intraarticular injection of a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (Cingal) to provide symptomatic relief of osteoarthritis of the knee: a randomized, double-blind, placebo-controlled multicenter clinical trial. Cartilage. 2017;101518378:1947603517703732.","journal-title":"Cartilage"},{"issue":"100968565","key":"657_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1471-2474-12-221","volume":"12","author":"T-L Huang","year":"2011","unstructured":"Huang T-L, Chang C-C, Lee C-H, Chen S-C, Lai C-H, Tsai C-L. Intra-articular injections of sodium hyaluronate (Hyalgan) in osteoarthritis of the knee: a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord. 2011;12(100968565):221.","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"657_CR65","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/ard.2009.118042","volume":"69","author":"A Jorgensen","year":"2010","unstructured":"Jorgensen A, Stengaard-Pedersen K, Simonsen O, Pfeiffer-Jensen M, Eriksen C, Bliddal H, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis. 2010;69(6):1097\u2013102.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"657_CR66","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/rheumatology\/41.11.1240","volume":"41","author":"J Karlsson","year":"2002","unstructured":"Karlsson J, Sjogren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford, England). 2002;41(11):1240\u20138.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"4","key":"657_CR67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00296-005-0611-0","volume":"26","author":"N Kotevoglu","year":"2006","unstructured":"Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int. 2006;26(4):325\u201330.","journal-title":"Rheumatol Int"},{"issue":"2","key":"657_CR68","first-page":"63","volume":"101","author":"E Kul-Panza","year":"2010","unstructured":"Kul-Panza E, Berker N. Is hyaluronate sodium effective in the management of knee osteoarthritis? A placebo-controlled double-blind study. Miner Med. 2010;101(2):63\u201372.","journal-title":"Miner Med"},{"issue":"3","key":"657_CR69","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/archinte.162.3.292","volume":"162","author":"RJ Petrella","year":"2002","unstructured":"Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2002;162(3):292\u20138.","journal-title":"Arch Intern Med"},{"issue":"4","key":"657_CR70","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1063-4584(05)80329-2","volume":"1","author":"W Puhl","year":"1993","unstructured":"Puhl W, Bernau A, Greiling H, Kopcke W, Pforringer W, Steck KJ, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthr Cartil. 1993;1(4):233\u201341.","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"657_CR71","first-page":"295","volume":"88","author":"RS Salk","year":"2006","unstructured":"Salk RS, Chang TJ, D\u2019Costa WF, Soomekh DJ, Grogan KA. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Jt Surg Am. 2006;88(2):295\u2013302.","journal-title":"J Bone Jt Surg Am"},{"issue":"5","key":"657_CR72","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.arth.2014.12.012","volume":"30","author":"W van der Weegen","year":"2015","unstructured":"van der Weegen W, Wullems JA, Bos E, Noten H, van Drumpt RA. No difference between intra-articular injection of hyaluronic acid and placebo for mild to moderate knee osteoarthritis: a randomized, controlled, double-blind trial. J Arthroplasty. 2015;30(5):754\u20137. https:\/\/doi.org\/10.1016\/j.arth.2014.12.012 .","journal-title":"J Arthroplasty"},{"issue":"1","key":"657_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2009.04.001","volume":"39","author":"RD Altman","year":"2009","unstructured":"Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum. 2009;39(1):1\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"657_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/ard.2009.127183","volume":"70","author":"I Atchia","year":"2011","unstructured":"Atchia I, Kane D, Reed MR, Isaacs JD, Birrell F. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis. 2011;70(1):110\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"657_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/ard.2008.094623","volume":"69","author":"X Chevalier","year":"2010","unstructured":"Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL, et al. Single, intra-articular treatment with 6\u00a0ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010;69(1):113\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"657_CR76","first-page":"775","volume":"31","author":"R Day","year":"2004","unstructured":"Day R, Brooks P, Conaghan PG, Petersen M, Multicenter Trial Group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31(4):775\u201382.","journal-title":"J Rheumatol."},{"issue":"2","key":"657_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1063-4584(05)80024-X","volume":"1","author":"M Dougados","year":"1993","unstructured":"Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1\u00a0year placebo-controlled trial. Osteoarthr Cartil. 1993;1(2):97\u2013103.","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"657_CR78","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/ard.53.8.529","volume":"53","author":"EB Henderson","year":"1994","unstructured":"Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis. 1994;53(8):529\u201334.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"657_CR79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12891-017-1585-2","volume":"18","author":"Y Henrotin","year":"2017","unstructured":"Henrotin Y, Berenbaum F, Chevalier X, Marty M, Richette P, Rannou F. Reduction of the serum levels of a specific biomarker of cartilage degradation (Coll2-1) by hyaluronic acid (KARTILAGE CROSS) compared to placebo in painful knee osteoarthritis patients: the EPIKART Study, a pilot prospective comparative randomized double blind trial. BMC Musculoskelet Disord. 2017;18(1):222.","journal-title":"BMC Musculoskelet Disord."},{"issue":"1","key":"657_CR80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jhsa.2007.10.009","volume":"33","author":"BE Heyworth","year":"2008","unstructured":"Heyworth BE, Lee JH, Kim PD, Lipton CB, Strauch RJ, Rosenwasser MP. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg. 2008;33(1):40\u20138.","journal-title":"J Hand Surg"},{"issue":"7","key":"657_CR81","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/rheumatology\/38.7.602","volume":"38","author":"EC Huskisson","year":"1999","unstructured":"Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford, England). 1999;38(7):602\u20137.","journal-title":"Rheumatology (Oxford, England)."},{"issue":"6","key":"657_CR82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1742-1241.2003.tb10535.x","volume":"57","author":"RW Jubb","year":"2003","unstructured":"Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500\u2013730\u00a0kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57(6):467\u201374.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"657_CR83","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jse.2012.10.040","volume":"22","author":"YW Kwon","year":"2013","unstructured":"Kwon YW, Eisenberg G, Zuckerman JD. Sodium hyaluronate for the treatment of chronic shoulder pain associated with glenohumeral osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. J Shoulder Elbow Surg. 2013;22(5):584\u201394.","journal-title":"J Shoulder Elbow Surg"},{"issue":"7","key":"657_CR84","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/ard.55.7.424","volume":"55","author":"LS Lohmander","year":"1996","unstructured":"Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis. 1996;55(7):424\u201331.","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"657_CR85","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/03009740701813103","volume":"37","author":"C Lundsgaard","year":"2008","unstructured":"Lundsgaard C, Dufour N, Fallentin E, Winkel P, Gluud C. Intra-articular sodium hyaluronate 2\u00a0mL versus physiological saline 20\u00a0mL versus physiological saline 2\u00a0mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol. 2008;37(2):142\u201350.","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"657_CR86","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/ard.2011.153049","volume":"70","author":"SE Munteanu","year":"2011","unstructured":"Munteanu SE, Zammit GV, Menz HB, Landorf KB, Handley CJ, Elzarka A, et al. Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial. Ann Rheum Dis. 2011;70(10):1838\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"657_CR87","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1136\/ard.2011.152017","volume":"70","author":"F Navarro-Sarabia","year":"2011","unstructured":"Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la Serna AR, Naranjo A, et al. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70(11):1957\u201362. https:\/\/doi.org\/10.1136\/ard.2011.152017 .","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"657_CR88","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10067-007-0834-4","volume":"27","author":"RJ Petrella","year":"2008","unstructured":"Petrella RJ, Cogliano A, Decaria J. Combining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Clin Rheumatol. 2008;27(8):975\u201381.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"657_CR89","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/ard.2003.019703","volume":"63","author":"T Pham","year":"2004","unstructured":"Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1\u00a0year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis. 2004;63(12):1611\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"657_CR90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.joca.2005.09.007","volume":"14","author":"E Qvistgaard","year":"2006","unstructured":"Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthr Cartil. 2006;14(2):163\u201370.","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"657_CR91","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/art.24301","volume":"60","author":"P Richette","year":"2009","unstructured":"Richette P, Ravaud P, Conrozier T, Euller-Ziegler L, Mazieres B, Maugars Y, et al. Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum. 2009;60(3):824\u201330.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"657_CR92","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.joca.2012.01.013","volume":"20","author":"V Strand","year":"2012","unstructured":"Strand V, Baraf HS, Lavin PT, Lim S, Hosokawa H. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthr Cartil. 2012;20(5):350\u20136. https:\/\/doi.org\/10.1016\/j.joca.2012.01.013 .","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"657_CR93","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0149-2918(98)80052-0","volume":"20","author":"M Wobig","year":"1998","unstructured":"Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther. 1998;20(3):410\u201323.","journal-title":"Clin Ther"},{"key":"657_CR94","unstructured":"Chou R, McDonagh MS, Nakamoto E, Griffin J. Analgesics for osteoarthritis: an update of the 2006 Comparative Effectiveness Review. Comparative Effectiveness Review No. 38. October 2011. AHRQ Publication No. 11(12)-EHC076-EF. Rockville, MD: Agency for Healthcare Research and Quality. https:\/\/effectivehealthcare.ahrq.gov\/topics\/osteoarthritis-pain\/research . Accessed 27 Apr 2018."},{"issue":"11","key":"657_CR95","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrrheum.2012.152","volume":"8","author":"TE McAlindon","year":"2012","unstructured":"McAlindon TE, Bannuru RR. Osteoarthritis: is viscosupplementation really so unsafe for knee OA? Nat Rev Rheumatol. 2012;8(11):635\u20136. https:\/\/doi.org\/10.1038\/nrrheum.2012.152 .","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"657_CR96","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.semarthrit.2014.12.003","volume":"44","author":"M Cutolo","year":"2014","unstructured":"Cutolo M, Berenbaum F, Hochberg M, Punzi L, Reginster JY. Commentary on recent therapeutic guidelines for osteoarthritis. Semin Arthritis Rheum. 2014;44(6):611\u20137. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.12.003 .","journal-title":"Semin Arthritis Rheum"},{"key":"657_CR97","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1743-422X-8-141","volume":"8","author":"C Cermelli","year":"2011","unstructured":"Cermelli C, Cuoghi A, Scuri M, Bettua C, Neglia RG, Ardizzoni A, et al. In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. Virol J. 2011;8:141. https:\/\/doi.org\/10.1186\/1743-422X-8-141 .","journal-title":"Virol J."},{"issue":"4","key":"657_CR98","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1902\/jop.1999.70.4.370","volume":"70","author":"P Pirnazar","year":"1999","unstructured":"Pirnazar P, Wolinsky L, Nachnani S, Haake S, Pilloni A, Bernard GW. Bacteriostatic effects of hyaluronic acid. J Periodontol. 1999;70(4):370\u20134. https:\/\/doi.org\/10.1902\/jop.1999.70.4.370 .","journal-title":"J Periodontol"},{"issue":"9","key":"657_CR99","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2106\/00004623-200209000-00015","volume":"84-A","author":"SS Leopold","year":"2002","unstructured":"Leopold SS, Warme WJ, Pettis PD, Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (Synvisc) in patients receiving more than one course of treatment. J Bone Jt Surg Am. 2002;84-A(9):1619\u201323.","journal-title":"J Bone Jt Surg Am."},{"issue":"9","key":"657_CR100","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.joca.2005.04.012","volume":"13","author":"M Pagnano","year":"2005","unstructured":"Pagnano M, Westrich G. Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthr Cartil. 2005;13(9):751\u201361. https:\/\/doi.org\/10.1016\/j.joca.2005.04.012 .","journal-title":"Osteoarthr Cartil"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-019-00657-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T07:46:02Z","timestamp":1694850362000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-019-00657-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":100,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["657"],"URL":"https:\/\/doi.org\/10.1007\/s40266-019-00657-w","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"9 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"G. Honvo was funded by the ESCEO, a Belgian not-for-profit organization. The ESCEO Working Group was entirely funded by the ESCEO. The ESCEO receives unrestricted educational grants, to support its educational and scientific activities, from non-governmental organizations, not-for-profit organizations, non-commercial and corporate partners. The choice of topics, participants, content and agenda of the working groups as well as the writing, editing, submission and reviewing of the manuscript are under the sole responsibility of the ESCEO, without any influence from third parties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"O. Bruy\u00e8re reports grants from Biophytis, IBSA, MEDA, Servier, SMB, and Theramex, outside of the submitted work. C. Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB, outside of the submitted work. J.-Y. Reginster reports grants from IBSA-Genevrier, Mylan, CNIEL, and Radius Health (through institution); consulting fees from IBSA-Genevrier, Mylan, CNIEL, Radius Health, and Pierre Fabre; fees for participation in review activities from IBSA-Genevrier, Mylan, CNIEL, Radius Health, and Teva; payment for lectures from AgNovos, CERIN, CNIEL, Dairy Research Council (DRC), Echolight, IBSA-Genevrier, Mylan, Pfizer Consumer Health, Teva, and Theramex, outside of the submitted work. B. Avouac reports consulting fees from Novartis, BMS, Roche, Janssen Cilag, Expanscience, and IRIS, and fees for participating in research activities from Sanofi, Amgen, Takeda, Allegan, AbbVie, Vertex, AstraZeneca, Ipsen, Leadiant, Otsuka, Jazz, Leo and Alexion, outside of the submitted work. E. Curtis reports lecture fees and travel support from Eli Lilly, Pfizer and UCB, outside of the submitted work. N. Fuggle reports travel support from Eli Lilly and Pfizer, outside of the submitted work. N. Arden reports personal fees from Bioventus, Flexion, Merck, Pfizer\/Lilly, Regeneron, Smith & Nephew, and Freshfields Bruckhaus Deringer and grants from Bioiberica and Merck, outside the submitted work. F. Rannou reports grants from APHP, INSERM, University Paris Descartes, and Arthritis (Road Network), and consulting fees from Pierre Fabre, Expanscience, Thuasne, Servier, Genevrier, Sanofi Aventis, and Genzyme, outside of the submitted work. T. McAlindon reports fees for participation in review activities from Pfizer and fees for consulting activities with Flexion, Samumed, Sanofi, Visgo, Roche, Astellas, Pfizer, Seikayaku, Regeneron, and Anika, outside of the submitted work. G. Honvo, X. Rygaert, A. Geerinck, V. Rabenda and A. Charles report nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of interests"}}]}}